Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Study Evaluating Eltrombopag Concentrations in Breast Milk of Nursing Mothers Taking Eltrombopag

NCT01055600 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01055600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01055600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Study Evaluating Eltrombopag Concentrations in Breast Milk of Nursing Mothers Taking Eltrombopag
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2013
Completion date
July 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopaenia